Article Text

other Versions

Use of indocyanine green for ureteric illumination and visualization
Free
  1. Helena M Obermair1,2,
  2. Santiago Scasso3,
  3. Joel Laufer4 and
  4. Andreas Obermair5
  1. 1Department of Obstetrics and Gynaecology, Royal North Shore Hospital, Sydney, New South Wales, Australia
  2. 2University of Sydney, Sydney, New South Wales, Australia
  3. 3Gynaecology Department, British Hospital, Montevideo, Uruguay
  4. 4School of Medicine, Universidad de la Republica Uruguay, Montevideo, Uruguay
  5. 5Queensland Centre for Gynaecological Cancer Research, Faculty of Medicine, Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia
  1. Correspondence to Professor Andreas Obermair, Queensland Centre for Gynaecological Cancer, Herston/Brisbane, QLD 4029, Australia; ao{at}surgicalperformance.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The ureters arise from the renal pelvis and track towards the bladder in close proximity to important vascular structures (aorta and inferior vena cava; common, external and internal iliac vessels), and pelvic organs, which make it vulnerable to intra-operative injury. The risk of ureteric injury at laparoscopic hysterectomy is approximately 0.5%, but can vary depending on risk factors.1

The distal (pelvic) part of the ureter is most exposed to iatrogenic injury. Risk of injury increases with complexity of the planned surgical procedure, distorted anatomy, and surgical technique/skill (eg, learning curve during robotic surgery). Injuries occur through the surgeon being unaware of the proximity of the ureter(s), which may lead to intra-operative misjudgment.

Intra-operative fluorescent-guided medical imaging of ureters is off-label and novel. Intravenous injection of near-infrared fluorescent agents is under pre-clinical development. A practical solution is the intra-operative injection of indocyanine green (ICG) into the ureter through a cystoscopy (retrograde) approach.

ICG is prepared for injection in a 10 mL syringe. A normal saline cystoscopy is performed with a secondary laparoscopic stack allowing simultaneous laparoscopic and cystoscopic views. Bladder intactness is checked, both ureteric orifices are located, ureteric catheters (7 French) are inserted over a guidewire 5 to 10 cm into one or both ureters, and ICG is injected (5 mL each side). The ureteric catheter(s) is removed and an indwelling catheter is placed. At laparoscopy, the injected ureter is visualized immediately (see Online Supplemental File 1).

Supplemental material

Our video article demonstrates the use of ICG in a patient who underwent a laparoscopic hysterectomy, 5 years following a radical trachelectomy for stage IB1 cervical adenosquamous carcinoma previously. The retroperitoneum was highly distorted and white light laparoscopic surgical assessment failed to identify the ureters.

This technique has been described in laparoscopic,2 colorectal surgery,3 and gynecological surgery.4 This article demonstrates the use of this technique in the setting of distorted anatomy and significant adhesions.

Video 1 Use of ICG for intra-operative ureteric illumination at laparoscopic hysterectomy
Figure 1

Image from video, demonstrating indocyanine green illumination of right ureter on right pelvic sidewall.

Data availability statement

There are no data in this work.

Ethics statements

Patient consent for publication

Ethics approval

This study involves human participants. In keeping with other major ethics committees, the institutions of the authors do not require formal ethics approval for case reports, where explicit patient consent is provided, as in this case. The study participant gave written informed consent to produce a video for teaching, medical education, research and publication on- and offline.

References

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Footnotes

  • Contributors AO contributed by research project conception, patient recruitment, drafting and editing the manuscript. HO drafted and edited the manuscript, recorded and edited the surgical video. SS and JL contributed by research project conception and editing the manuscript. AO is responsible for the overall content as guarantor.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests Professor A Obermair declares the following conflicts: consulting fees and travel support from AstraZeneca Australia, GSK and Stryker; ownership of shares in Surgical Performance Pty Ltd.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

Linked Articles